COVID-19 has caused significant disruptions to tuberculosis (TB) services in India – which has the highest burden of TB cases globally. Not only may people with TB be uniquely vulnerable to severe complications from COVID-19, if infected – but the pandemic has also disrupted already-stretched systems of delivering TB care, and lockdowns have made much-needed social support increasingly difficult to come by.
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
Janssen India, the pharmaceutical division of Johnson & Johnson Private Limited, is proud to announce that the Company has been honored with CSR Health Impact’s prestigious Swasth Bharat award in recognition of its comprehensive and transformative work to support India’s efforts to address the growing challenge of multidrug-resistant tuberculosis (MDR-TB).
We are pleased with the conclusion of the Rajasthan FDA, which confirms that Johnson’s Baby Shampoo does not contain formaldehyde. This outcome reaffirms our own testing and the longstanding assurance we have that Johnson’s Baby Shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients. Importantly, this is the result of the appellate laboratory, following a magistrate court order for re-testing, and overrules an earlier test result that was erroneous. Nothing is more important to us than the safety of the people who use our products, and our quality assurance process is rigorous – meeting or exceeding standards in every country where our products are sold.
India accounts for more than a quarter of the global burden of tuberculosis (TB), and for this reason is often called the TB capital of the world. 1 In a recent report titled, India Health of Nation’s States, TB was listed as one of the top ten causes of death in the country. 2 In recent years, the rapid emergence of multidrug-resistant TB (MDR-TB) – which does not respond to at least two of the most commonly used TB treatments – has made the situation worse.
Johnson & Johnson India has announced a strategic partnership with the Government of Maharashtra to implement focused disease interventions that have the potential to significantly improve the health of people and strengthen health care in the state.
This July Fourth, as the U.S. celebrates its birth as an independent country, we're looking back at the many ways the company has been there for new mothers and their babies in the U.S.—and beyond—for over a century.
This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.